SR 59230A hydrochloride
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 5mg | ¥1920.00 | 10-15工作日发货 | |
| 10mg | ¥3072.00 | 10-15工作日发货 | |
| 25mg | ¥6335.00 | 10-15工作日发货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
R 59230A hydrochloride is a selective and potent antagonist of β3 adrenoceptor, with IC50 values being 40, 408, and 648 nM for β3, β1, and β2 adrenergic receptors, respectively. β3 adrenoceptor, predominately located in adipose tissue, is mainly responsible for the regulation of lipolysis and thermogenesis. In addition, β3 adrenoceptor has also been found to be involved in different tumor conditions, such as neuroblastoma, via the regulation of the bioactive lipid sphingosine 1-phosphate metabolism and signaling.
References:
1. Nisoli E, Tonello C, Landi M, et al. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Molecular Pharmacology, 1996, 49(1): 7-14.
2. Kanzler SA, Januario AC, Paschoalini MA. Involvement of β3-adrenergic receptors in the control of food intake in rats. Brazilian Journal of Medical and Biological Research, 2011, 44(11): 1141-1147.
3. Bruno G, Cencetti F, Pini A, et al. β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation. Oncogene, 2020, 39(2): 368-384.
4. Bexis S, Docherty JR. Role of α1- and β3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse. British Journal of Pharmacology, 2009, 158(1): 259-266.
产品性质
| 物理外观 | White solid |
| CAS号 | 1135278-41-9 |
| 分子式 | C21H27NO2·HCl |
| 分子量 | 361.91 |
| 小分子别名 | SR59230A hydrochloride |
| 化学名称 | (S)-1-(2-ethylphenoxy)-3-(((S)-1,2,3,4-tetrahydronaphthalen-1-yl)amino)propan-2-ol hydrochloride |
| 溶解度 | Soluble in DMSO |
| SMILES | CCc(cccc1)c1OC[C@H](CN[C@@H](CCC1)c2c1cccc2)O.Cl |
| 存储条件 | 室温 |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | SR59230A 盐酸盐是一种强效、具有选择性和血脑屏障穿透性的 β3 肾上腺素能受体拮抗剂,对 β3、β1 和 β2 受体的 IC50 分别为 40、408 和 648 nM。 |



沪公网安备 31011002003500